ProShare Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-36,500
| Closed | -$648K | – | 1788 |
|
|
2018
Q3 | $648K | Sell |
36,500
-1,269
| -3% | -$21.8K | ﹤0.01% | 1002 |
|
|
2018
Q2 | $521K | Buy |
37,769
+7,157
| +23% | +$84.9K | ﹤0.01% | 1100 |
|
|
2018
Q1 | $278K | Buy |
30,612
+4,817
| +19% | +$26.6K | ﹤0.01% | 1364 |
|
|
2017
Q4 | $110K | Buy |
+25,795
| New | +$123K | ﹤0.01% | 1724 |
|
|
2016
Q4 | – | Sell |
-30,401
| Closed | -$94K | – | 1765 |
|
|
2016
Q3 | $94K | Sell |
30,401
-5,627
| -16% | -$17.5K | ﹤0.01% | 1420 |
|
|
2016
Q2 | $116K | Buy |
36,028
+585
| +2% | +$2.14K | ﹤0.01% | 1509 |
|
|
2016
Q1 | $110K | Sell |
35,443
-3,781
| -10% | -$12.3K | ﹤0.01% | 1508 |
|
|
2015
Q4 | $157K | Buy |
39,224
+3,632
| +10% | +$16.7K | ﹤0.01% | 1593 |
|
|
2015
Q3 | $163K | Sell |
35,592
-2,648
| -7% | -$13.9K | ﹤0.01% | 1346 |
|
|
2015
Q2 | $198K | Sell |
38,240
-2,530
| -6% | -$15.2K | ﹤0.01% | 1517 |
|
|
2015
Q1 | $255K | Buy |
40,770
+5,187
| +15% | +$29.9K | ﹤0.01% | 1566 |
|
|
2014
Q4 | $224K | Sell |
35,583
-553
| -2% | -$3.37K | ﹤0.01% | 1693 |
|
|
2014
Q3 | $220K | Sell |
36,136
-7,126
| -16% | -$48.7K | ﹤0.01% | 1918 |
|
|
2014
Q2 | $285K | Sell |
43,262
-15,247
| -26% | -$172K | ﹤0.01% | 1945 |
|
|
2014
Q1 | $1.39M | Buy |
58,509
+40,382
| +223% | +$586K | 0.02% | 1025 |
|
|
2013
Q4 | $194K | Sell |
18,127
-13,780
| -43% | -$152K | ﹤0.01% | 1261 |
|
|
2013
Q3 | $425K | Buy |
31,907
+5,781
| +22% | +$91.4K | 0.01% | 1614 |
|
|
2013
Q2 | $343K | Buy |
+26,126
| New | +$352K | 0.01% | 1601 |
|